US Oncology notes to be repaid or refinanced in buyout by McKesson

By Susanna Moon

Chicago, Nov. 1 - US Oncology Holdings, Inc.'s senior floating-rate pay-in-kind toggle notes due 2012 and US Oncology, Inc.'s 9 1/8% senior secured notes due 2017 and 10¾% senior subordinated notes due 2014 are expected to be repaid or refinanced in connection with the planned acquisition of the company by McKesson Corp.

McKesson said it plans to purchase all outstanding shares of US Oncology for cash. The total deal, including the assumption of US Oncology's outstanding debt, is valued at about $2.16 billion.

US Oncology is a Woodlands, Texas-based provider of cancer treatment and research services. McKesson is a San Francisco-based health-care services and information technology company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.